We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Calf Muscle Atrophy After Achilles Tendon Rupture. A Clinical-Radiological-Biomechanical Multicenter Study.

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01778816
First Posted: January 29, 2013
Last Update Posted: January 29, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Hospital Fribourg, Switzerland
Hospital Liestal, Switzerland
Information provided by (Responsible Party):
Claudio Rosso, University Hospital, Basel, Switzerland
  Purpose

Multicenter Achilles tendon study Switzerland. Comparing three mainstream treatment types: open, percutaneous and conservative (non-operative) treatments.

Comparing force torque measurements, muscle volume and clinical scores.


Condition
Achilles Tendon Ruptures

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective

Resource links provided by NLM:


Further study details as provided by Claudio Rosso, University Hospital, Basel, Switzerland:

Primary Outcome Measures:
  • Muscle Volume [ Time Frame: at least 3 years after injury ]

Enrollment: 52
Study Start Date: January 2009
Study Completion Date: December 2011
Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
  • Age 20-65 years
  • BMI < 40
  • no injury to leg
  • no injury on contralateral leg
Criteria

Inclusion Criteria:

  • 20-65 years of age,
  • a healthy, contralateral leg
  • physiological, clinically determined alignment of the knee, foot and ankle
  • no trauma to the healthy leg
  • no neuromuscular impairments including muscle dystrophies
  • no other posttraumatic injuries or osteoarthritis of the knee, foot or ankle of the affected leg.

Exclusion Criteria:

  • re-rupture or reoperation of the Achilles tendon
  • surgical site infection
  • neuromuscular diseases including muscle dystrophies
  • ankle valgus of more than 15° or ankle varus of more than 5°
  • other known pathologies of the non-affected leg
  • general MRI exclusion criteria (e.g. pacemaker, other metal not qualifying for an MRI, tattoos and claustrophobia)
  • body mass index (BMI) of > 40 kg/m2
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Claudio Rosso, Claudio Rosso MD MSc, University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier: NCT01778816     History of Changes
Other Study ID Numbers: RossoAchilles
First Submitted: January 25, 2013
First Posted: January 29, 2013
Last Update Posted: January 29, 2013
Last Verified: January 2013

Keywords provided by Claudio Rosso, University Hospital, Basel, Switzerland:
Achilles tendon, muscle volume, Achilles tendon length, force, ATRS, Hannover, AOFAS

Additional relevant MeSH terms:
Rupture
Wounds and Injuries